Compound class:
Synthetic organic
Comment: RMC-6291 is a KRASG12C(ON) inhibitor [1], that inhibits active, GTP-bound RAS. It is designed to bind to the immunophilin cyclophilin A (PPIA) via a moiety containing a minimal cyclophilin A-binding motif of the naturally ocurring immunosuppressive (cyclophilin inhibiting) polyketide Sanglifehrin A. It also contains a cysteine-reactive warhead to mediate covalent tethering to KRAS. The resulting RMC-6291:cyclophilin A structure has high affinity for the active state of KRASG12C and forms a RMC-6291:cyclophilin A:KRASG12C tri-complex that causes steric hindrance for RAS effector binding thus blocking oncogenic signalling. The chemical structure of RMC-6291 was disclosed during the 'First Disclosures of New Drug Candidates' session at the April 2023 meeting of the AACR in Orlando. RMC-6291 was developed for anti-tumour potential.
|
|
Classification | |
Compound class | Synthetic organic |
Database Links | |
GtoPdb PubChem SID | 479821412 |
PubChem CID | 167993669 |
Search Google for chemical match using the InChIKey | HJNFYLSFWYRSHS-JVFAQLKDSA-N |
Search Google for chemicals with the same backbone | HJNFYLSFWYRSHS |
UniChem Compound Search for chemical match using the InChIKey | HJNFYLSFWYRSHS-JVFAQLKDSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | HJNFYLSFWYRSHS-JVFAQLKDSA-N |